NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer

Image: NanOlogy has enrolled first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer. Photo: courtesy of rajcreationzs / FreeDigitalPhotos.net.